Table 1.

Results of the variants with BFDP < 15% in the meta-analysis of the 12 studies of breast cancer-specific mortality

Subgroup	Variant	Chr	Position	Alt	Ref	Eaf_Ref	HR	LCL	UCL	P value	BFDP
ER-negative	rs67918676:27445956:A:AT	7	27445956	AT	A	0.12	1.27	1.16	1.39	1.38 × 10−7	0.11
ER-negative	rs192185001:27448012:A:AT	7	27448012	AT	A	0.12	1.27	1.16	1.39	1.66 × 10−7	0.13
ER-negative	rs145963877:27473909:CAG:C	7	27473909	C	CAG	0.11	1.28	1.17	1.41	1.91 × 10−7	0.15
ER-positive	rs4717568:70400700:T:C	7	70400700	C	T	0.62	0.88	0.8	0.92	1.28 × 10−7	0.07
ER-positive	rs1917618:70396442:T:A	7	70396442	A	T	0.62	0.88	0.84	0.93	1.46 × 10−7	0.08
ER-positive	rs1546774:70398441:T:G	7	70398441	G	T	0.62	0.88	0.84	0.93	1.66 × 10−7	0.09
ER-positive	rs1546773:70398437:T:C	7	70398437	C	T	0.62	0.88	0.84	0.93	1.81 × 10−7	0.10
All	rs370332736:50395136:AACTT:A	6	50395136	A	AACTT	0.09	1.16	1.10	1.24	2.48 × 10−7	0.13